A phase 2b clinical study assessing MLR-1019 (armesocarb)
Latest Information Update: 04 Aug 2021
At a glance
- Drugs Mesocarb (Primary)
- Indications Dyskinesias; Parkinson's disease
- Focus Therapeutic Use
- Sponsors Melior Pharmaceuticals, Inc.
- 04 Aug 2021 New trial record